Indo Us Bio-Tech Ltd

Financials & approval

• Board approved standalone unaudited results for quarter ended June 30, 2026; Limited Review Report attached.
• Basic EPS ₹1.51; Diluted EPS not provided.
• Auditor's review completed; no material misstatement identified.
• Board meeting held 12 Aug 2026; timings 14:30–15:10.

Financial results approved

• Unaudited standalone financial results for quarter ended 30 June 2026 approved by Board; Audit Committee reviewed.
• Statement accompanied by limited review report from auditor.
• Period: quarter ended 30 June 2026; standalone results.
• Major product segment disclosed as Seed Cultivation, Processing & Trading.
• Auditor's review indicates no material misstatement; unmodified opinion.
• Board meeting date: 12 August 2026.
• Auditor: Bhagat & Associates; Independent Auditor's Review Report under Regulation 33.

Regulatory/compliance notes

• Statement filed per SEBI LODR Regulation 33; independent limited review conducted.

Committee reconstitution

• Audit Committee reconstituted: Ritaben Kikani (Chair), Shilpa Thumar, Jagdishkumar Ajudiya, Hemanshi Soni (Members).
• Nomination and Remuneration Committee: Shilpa Thumar (Chair); Ritaben Kikani; Hemanshi Soni (Members).
• Stakeholders Relationship Committee: Ritaben Kikani (Chair); Jagdishkumar Ajudiya; Hemanshi Soni; Shilpa Thumar (Members).
• Effective date of reconstitution: 21 April 2026; other disclosures remain unchanged.

Auditor change

• Gautam N Associates resigned as statutory auditor effective 15 June 2026.
• Board approved Bhagat & Associates as statutory auditor on 16 June 2026.
• Appointment term until the next General Meeting, subject to shareholders' approval.
• Previous term: Gautam N Associates appointed 30-09-2020; current term through 26th AGM.
• Reason for change: administrative and operational restructuring of audit assignments.
• New auditor: Bhagat & Associates, FRN 101100W, Ahmedabad.
• Old auditor: Gautam N Associates, FRN 103117W.
• Consent and eligibility confirmed; appointment subject to statutory/regulatory approvals.

Committee changes and new independent director

• Audit Committee reconstituted: Ritaben Kikani (Chair); Hemanshi Soni added as Member.
• Nomination and Remuneration Committee reconstituted: Shilpa Thumar (Chair); Ritaben Kikani and Hemanshi Soni as Members.
• Stakeholders Relationship Committee reconstituted: Ritaben Kikani (Chair); Hemanshi Soni and Shilpa Thumar as Members.
• Resignation of Nehaben Patel (Non-Executive Independent Director) triggered committee changes.
• Hemanshi Darsh Soni appointed Additional Director (Independent) on Apr 21, 2026.
• Appointment subject to shareholders' approval.
• Reconstitution effective July 10, 2026.
• New committee compositions reflect Hemanshi Soni's addition post-resignation.

Dematerialisation status

• No dematerialisation requests were received during the period.
• No physical certificates were mutilated or cancelled due to dematerialisation.
• No substitution of depository name as registered owner within 15 days.

Purpose

• Postal ballot seeks shareholder consent for two governance resolutions via e-voting.

Resolution 1: Regularization of Independent Director

• Special resolution to regularize Hemanshi Darsh Soni as Independent Director for a five-year term from 21.04.2026.
• Outcome: Pending; results to be announced by 5 August 2026.

Resolution 2: Appointment of Statutory Auditors

• Ordinary resolution to appoint M/s Bhagat & Associates as Statutory Auditors to fill casual vacancy.
• Outcome: Pending; results to be announced by 5 August 2026.